symptomatic benign prostatic hyperplasia (BPH) (DBCOND0099889)
Identifiers
- Synonyms
- Symptomatic Benign Prostatic Hyperplasia / Symptomatic Benign Prostatic Hyperplasia (BPH)
Associated Data
- Indicated Drugs and Targets
Drug Description Targets Dutasteride An antiandrogenic compound that is used for the treatment of symptomatic benign prostatic hyperplasia (BPH) in adult males by inhibiting 5-alpha reductase.- 3-oxo-5-alpha-steroid 4-dehydrogenase 1target
- 3-oxo-5-alpha-steroid 4-dehydrogenase 2target
- Sodium-dependent dopamine transportertransporter
- Synaptic vesicular amine transportertransporter
- Albumincarrier
- Alpha-1-acid glycoprotein 1carrier
- Cytochrome P450 3A5enzyme
- Polyprenal reductasetarget
Finasteride An antiandrogenic compound that is used for the treatment of symptomatic benign prostatic hyperplasia (BPH) and male pattern hair loss in adult males by inhibiting Type II 5-alpha reductase.- Clinical Trials
- Not Available